| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T H Tran, S Grey, J Anrather, F Steinhäuslin, F H Bach, H Winkle. Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection. Transplantation. vol 66. issue 9. 1998-12-02. PMID:9825805. |
immunologically privileged sites have been shown to express fas ligand (fasl) and may protect themselves by inducing apoptosis of infiltrating inflammatory cells. |
1998-12-02 |
2023-08-12 |
Not clear |
| H Sano, K Asano, S Minatoguchi, J Hiraoka, K Fujisawa, K Nishigaki, N Yasuda, H Kumada, M Takemura, H Ohashi, M Seishima, T Fujiwara, H Fujiwar. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis. Nephron. vol 80. issue 2. 1998-12-01. PMID:9736812. |
it has been reported that glomerular cells with apoptosis and positive fas immunoreactivity are seen in proliferative glomerulonephritis (pgn). |
1998-12-01 |
2023-08-12 |
Not clear |
| H Sano, K Asano, S Minatoguchi, J Hiraoka, K Fujisawa, K Nishigaki, N Yasuda, H Kumada, M Takemura, H Ohashi, M Seishima, T Fujiwara, H Fujiwar. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis. Nephron. vol 80. issue 2. 1998-12-01. PMID:9736812. |
fas induces apoptosis when it binds to fas ligand (fas-l) or soluble fas-l (sfas-l). |
1998-12-01 |
2023-08-12 |
Not clear |
| H Sano, K Asano, S Minatoguchi, J Hiraoka, K Fujisawa, K Nishigaki, N Yasuda, H Kumada, M Takemura, H Ohashi, M Seishima, T Fujiwara, H Fujiwar. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis. Nephron. vol 80. issue 2. 1998-12-01. PMID:9736812. |
however, soluble fas (sfas) blocks apoptosis by inhibiting binding between fas and fas-l or sfas-l. that is, fas, fas-l, and sfas-l are inducers of apoptosis, but sfas is an inhibitor of apoptosis. |
1998-12-01 |
2023-08-12 |
Not clear |
| C S Chung, Y X Xu, W Wang, I H Chaudry, A Ayal. Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Archives of surgery (Chicago, Ill. : 1960). vol 133. issue 11. 1998-12-01. PMID:9820353. |
is fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? |
1998-12-01 |
2023-08-12 |
Not clear |
| A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puc. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. The Journal of pediatrics. vol 133. issue 5. 1998-12-01. PMID:9821419. |
the clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a fas mutation that impairs lymphocyte apoptosis. |
1998-12-01 |
2023-08-12 |
Not clear |
| A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puc. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. The Journal of pediatrics. vol 133. issue 5. 1998-12-01. PMID:9821419. |
we identified a novel mutation in the intracellular apoptosis signaling domain of fas in 11 members of a family, individual members of which have been monitored for up to 25 years, with 1 or more features of alps. |
1998-12-01 |
2023-08-12 |
Not clear |
| K Miwa, M Asano, R Horai, Y Iwakura, S Nagata, T Sud. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nature medicine. vol 4. issue 11. 1998-11-30. PMID:9809553. |
caspase 1-independent il-1beta release and inflammation induced by the apoptosis inducer fas ligand. |
1998-11-30 |
2023-08-12 |
mouse |
| K Miwa, M Asano, R Horai, Y Iwakura, S Nagata, T Sud. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nature medicine. vol 4. issue 11. 1998-11-30. PMID:9809553. |
fas ligand is a well-characterized apoptosis inducer. |
1998-11-30 |
2023-08-12 |
mouse |
| K Miwa, M Asano, R Horai, Y Iwakura, S Nagata, T Sud. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nature medicine. vol 4. issue 11. 1998-11-30. PMID:9809553. |
these results demonstrate a newly discovered role for fas ligand in inflammation, and challenge the dogma that apoptosis does not induce inflammation. |
1998-11-30 |
2023-08-12 |
mouse |
| M Kokubun, A Kume, M Urabe, H Mano, M Okubo, R Kasukawa, A Kakizuka, K Ozaw. Apoptosis-mediated regulation of recombinant human granulocyte colony-stimulating factor production by genetically engineered fibroblasts. Gene therapy. vol 5. issue 7. 1998-11-30. PMID:9813663. |
in a previous study, cdna encoding the ligand-binding domain of the rat estrogen receptor was fused to the sequence for murine fas transmembrane and cytoplasmic regions, and expression of the fusion protein (mfaser) in l929 fibroblasts resulted in estrogen-dependent apoptosis. |
1998-11-30 |
2023-08-12 |
human |
| E O'Flaherty, S Ali, S J Pettit, J A Kirb. Examination of the sensitivity of T cells to Fas ligation: induction of allospecific apoptosis. Transplantation. vol 66. issue 8. 1998-11-25. PMID:9808493. |
examination of the sensitivity of t cells to fas ligation: induction of allospecific apoptosis. |
1998-11-25 |
2023-08-12 |
Not clear |
| F Benigni, S Sacco, L Aloe, P Ghezz. Intracerebroventricular injection of anti-Fas activates the hypothalamus-pituitary-adrenal axis and induces peripheral interleukin-6 and serum amyloid A in mice: comparison with other ligands of the tumor necrosis factor/nerve growth factor receptor superfamily. The American journal of pathology. vol 153. issue 5. 1998-11-25. PMID:9811328. |
fas is a receptor of the tumor necrosis factor (tnf)/ nerve growth factor (ngf) receptor superfamily that mediates apoptosis and some inflammatory changes. |
1998-11-25 |
2023-08-12 |
mouse |
| M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson, A Y Lin, M Raffeld, E S Jaff. Pathological findings in human autoimmune lymphoproliferative syndrome. The American journal of pathology. vol 153. issue 5. 1998-11-25. PMID:9811346. |
the defects in lymphocyte apoptosis that underlie the autoimmune lymphoproliferative syndrome (alps) are usually attributable to inherited mutations of the cd95 (fas) gene. |
1998-11-25 |
2023-08-12 |
human |
| W Lieberthal, J S Koh, J S Levin. Necrosis and apoptosis in acute renal failure. Seminars in nephrology. vol 18. issue 5. 1998-11-24. PMID:9754603. |
in some situations, receptor-mediated events induced by tumor necrosis factor-alpha (tnf-alpha) or fas (cd95) may play a role in apoptosis in arf. |
1998-11-24 |
2023-08-12 |
Not clear |
| J Tschopp, M Irmler, M Thom. Inhibition of fas death signals by FLIPs. Current opinion in immunology. vol 10. issue 5. 1998-11-24. PMID:9794838. |
the death receptor fas is a member of the tumor necrosis factor receptor family; upon interaction with its ligand it efficiently activates caspases and induces apoptosis. |
1998-11-24 |
2023-08-12 |
Not clear |
| N Kawahigashi, Y Furukawa, M Saito, K Usuku, M Osam. Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy. Journal of neuroimmunology. vol 90. issue 2. 1998-11-24. PMID:9817448. |
to determine if fas ligand (fasl) mediated apoptosis is involved in the pathogenesis of htlv-1-associated myelopathy/tropical spastic paraparesis (ham/tsp), we examined the expression of fasl mrna in fresh uncultured peripheral blood mononuclear cells (pbmc) from 17 japanese patients with ham/tsp, four adult t-cell leukemia/lymphoma (atl) patients, three asymptomatic htlv-1 carriers and three normal individuals. |
1998-11-24 |
2023-08-12 |
Not clear |
| B Beutler, F Bazzon. TNF, apoptosis and autoimmunity: a common thread? Blood cells, molecules & diseases. vol 24. issue 2. 1998-11-23. PMID:9645922. |
further, at least one autoimmune disease results from a defined defect of apoptosis (mutations of the fas ligand or its receptor). |
1998-11-23 |
2023-08-12 |
Not clear |
| C H Bird, V R Sutton, J Sun, C E Hirst, A Novak, S Kumar, J A Trapani, P I Bir. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Molecular and cellular biology. vol 18. issue 11. 1998-11-23. PMID:9774654. |
selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme b-mediated apoptosis without perturbing the fas cell death pathway. |
1998-11-23 |
2023-08-12 |
Not clear |
| C H Bird, V R Sutton, J Sun, C E Hirst, A Novak, S Kumar, J A Trapani, P I Bir. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Molecular and cellular biology. vol 18. issue 11. 1998-11-23. PMID:9774654. |
cytotoxic lymphocytes (cls) induce caspase activation and apoptosis of target cells either through fas activation or through release of granule cytotoxins, particularly granzyme b. cls themselves resist granule-mediated apoptosis but are eventually cleared via fas-mediated apoptosis. |
1998-11-23 |
2023-08-12 |
Not clear |